Patent details

Basic Information

Publication number:

92060

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP019884667

Legal Status:

Expired

Application number:

92060

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/98/063/001-007

Marketing Authorization Type:

Marketing Authorization Date:

14/08/2007

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

13/08/2012

First Marketing Authorization date:

14/08/2007

Grant date:

15/10/2012

Activation date:

26/10/2021

Publication date:

15/10/2012

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

14/08/2022

SPC Extension Expiration:

14/08/2022

Rejection date:

Withdrawal date:

Owner

From:

06/12/2018

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

History of Owners

From:

13/08/2012

To:

06/12/2018

Name:

NOVARTIS VACCINES AND DIAGNOSTICS, INC.

Address:

HORTON STREET 4560, EMERYVILLE, CALIFORNIA 94608, United States (US)

Agent

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

13/08/2012

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

CHOE MINNA

Address:

United States (US)

2

Name:

SHIRLEY BRET A.

Address:

United States (US)

3

Name:

BABUKA SUSAN

Address:

United States (US)

4

Name:

TELLERS MELANIE

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2019/01

Publication date:

09/01/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

SPC4

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

3

Bulletin Heading:

SPC3

Bulletin edition number:

2021/12

Publication date:

04/11/2021

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20180000430A

Date Registered:

06/12/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK (Luxembourg) LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/09/2021

Last Annual Fee Paid Number:

21

Last Annual Fee Paid Amount:

410 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
18/11/2015	Incoming Correspondence (Post)	2
02/01/2019	Publication	1
07/12/2018	Outgoing Correspondence	1
06/12/2018	Request For Change	3
02/01/2019	Outgoing Correspondence	1